[go: up one dir, main page]

EA001213B1 - Композиции жидкого алендроната - Google Patents

Композиции жидкого алендроната Download PDF

Info

Publication number
EA001213B1
EA001213B1 EA199900352A EA199900352A EA001213B1 EA 001213 B1 EA001213 B1 EA 001213B1 EA 199900352 A EA199900352 A EA 199900352A EA 199900352 A EA199900352 A EA 199900352A EA 001213 B1 EA001213 B1 EA 001213B1
Authority
EA
Eurasian Patent Office
Prior art keywords
formulation
acid
alendronic acid
sodium
aqueous liquid
Prior art date
Application number
EA199900352A
Other languages
English (en)
Russian (ru)
Other versions
EA199900352A1 (ru
Inventor
Маниш Дж. Неруркар
Вильям А. Ханке
Дразен Остовиц
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA199900352A1 publication Critical patent/EA199900352A1/ru
Publication of EA001213B1 publication Critical patent/EA001213B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA199900352A 1996-10-04 1997-10-02 Композиции жидкого алендроната EA001213B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2676596P 1996-10-04 1996-10-04
GBGB9700541.7A GB9700541D0 (en) 1997-01-13 1997-01-13 Liquid alendronate formulation
US3600297P 1997-01-22 1997-01-22
PCT/US1997/015740 WO1998014196A1 (en) 1996-10-04 1997-10-02 Liquid alendronate formulations

Publications (2)

Publication Number Publication Date
EA199900352A1 EA199900352A1 (ru) 1999-08-26
EA001213B1 true EA001213B1 (ru) 2000-12-25

Family

ID=27268667

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900352A EA001213B1 (ru) 1996-10-04 1997-10-02 Композиции жидкого алендроната

Country Status (20)

Country Link
EP (1) EP1007054A4 (xx)
JP (1) JP2001501222A (xx)
CN (1) CN1238691A (xx)
AU (1) AU723357B2 (xx)
BG (1) BG103306A (xx)
BR (1) BR9712197A (xx)
CA (1) CA2267370A1 (xx)
CZ (1) CZ116999A3 (xx)
EA (1) EA001213B1 (xx)
EE (1) EE03669B1 (xx)
HU (1) HUP0000125A3 (xx)
IL (1) IL129127A0 (xx)
IS (1) IS5012A (xx)
NO (1) NO991569L (xx)
NZ (1) NZ334836A (xx)
PL (1) PL332496A1 (xx)
SK (1) SK42999A3 (xx)
TR (1) TR199900730T2 (xx)
WO (1) WO1998014196A1 (xx)
YU (1) YU17499A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560490B2 (en) 2001-01-23 2009-07-14 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
WO2007031785A2 (en) * 2005-09-16 2007-03-22 Selamine Ltd Bisphosphonate formulation
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206209A (en) * 1978-11-02 1980-06-03 Kracauer Paul Sublingual aspirin tablet
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Also Published As

Publication number Publication date
CZ116999A3 (cs) 1999-09-15
CA2267370A1 (en) 1998-04-09
NO991569L (no) 1999-06-04
JP2001501222A (ja) 2001-01-30
NO991569D0 (no) 1999-03-30
AU723357B2 (en) 2000-08-24
IL129127A0 (en) 2000-02-17
EA199900352A1 (ru) 1999-08-26
HUP0000125A2 (hu) 2000-06-28
YU17499A (en) 1999-11-22
BG103306A (en) 2000-01-31
HUP0000125A3 (en) 2001-04-28
BR9712197A (pt) 1999-08-31
AU4644897A (en) 1998-04-24
EE03669B1 (et) 2002-04-15
CN1238691A (zh) 1999-12-15
PL332496A1 (en) 1999-09-13
EP1007054A4 (en) 2000-07-19
EE9900113A (et) 1999-10-15
SK42999A3 (en) 2000-01-18
NZ334836A (en) 2000-11-24
TR199900730T2 (xx) 1999-07-21
EP1007054A1 (en) 2000-06-14
IS5012A (is) 1999-03-26
WO1998014196A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
EP0939624B1 (en) Effervescent bisphosphonate formulation
RU2176507C2 (ru) Пероральные жидкие композиции, содержащие алендронат
ES2216017T3 (es) Formulaciones intravenosas de alendronato.
EP0524579B1 (en) Improved oral dosing formulations of dideoxy purine nucleosides
AU723357B2 (en) Liquid alendronate formulations
EP1067934B1 (en) Oral liquid solution comprising the antidepressant mirtazapine
ES2243457T3 (es) Composicion que comprende bifosfonatos para la prevencion y/o tratamiento de trastornos metabolicos de huesos, procedimiento de preparacion de dicha composicion y usos de la misma.
MXPA01010953A (es) Solucion oral de prucalopride.
AU2007294261B2 (en) Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore
KR20000048829A (ko) 액체 알렌드로네이트 제형
JP4195218B2 (ja) 弱アルカリで安定化される薬剤を含む医薬用液剤
US6265449B1 (en) Aqueous compositions comprising ranitidine and LCMT sucrose
GR1009069B (el) Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη
CN111246753A (zh) 用于钙补充的组合物
JP2009001592A (ja) 弱アルカリで安定化される薬剤を含む医薬用液剤
MXPA00009677A (en) Oral liquid antidepressant solution
JP2010043119A (ja) 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU